My October editorial1 generated three replies. Dr McGuigan2 argues that, to avoid delays, process rather than outcome is seminal to any assessment of the individual surgeon. I suggest that to the patient (I speak from experience), outcome is climacteric. Dr Tobias3 reminds us about the benefits of radiation and chemoradiation therapy, also reviewed lately by Geh et al.4 My editorial was aimed at prevention of another surgical outcomes scandal, not at defining 21st century treatment. Geh's article makes it plain that surgery for oesophageal cancer will be necessary for the foreseeable future. Let us make it as safe as possible. As for Professor Hughes5 with his comment on my Latin, to him I can only say quidquid praecipies, esto brevis. In three sanguine lines, I think he did just that.
References
- 1.Britton DC. Oesophageal cancer surgery. J R Soc Med 2001;94: 500-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.McGuigan CC. Oesophageal cancer surgery. J R Soc Med 2001;94: 658-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Tobias JS. Treatment of oesophageal cancer. J R Soc Med 2002;95: 55. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Geh JI, Crellin AM, Glynne-Jones R. Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer. Br J Surg 2001;88: 338-56 [DOI] [PubMed] [Google Scholar]
- 5.Hughes RA. Treatment of oesophageal cancer. J R Soc Med 2002;95: 55. [DOI] [PMC free article] [PubMed] [Google Scholar]
